OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Health Economics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial	159
Psychometric properties and general population reference values for PROMIS Global Health in Hungary	65
Education and medication use later in life and the role of intelligence	64
Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication	56
Patient-level cost analysis of subfertility pathways in the Dutch healthcare system	52
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries	47
Costing methodologies in European economic evaluation guidelines: commonalities and divergences	47
Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis	37
Correction to: Geographic distribution of physicians in Portugal	35
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland	33
Pragmatic randomized controlled trial comparing a complex telemedicine-based intervention with usual care in patients with chronic conditions	33
The hidden cost of sophistication: economic complexity and obesity	33
Comparing the measurement properties of the EQ-5D-Y-3L, EQ-5D-Y-5L and CHU9D in children and adolescents: a measurement property study	29
The Italian NHS at regional level: same in theory, different in practice	28
The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study	27
Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland	26
Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada	25
Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan	25
From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands	24
Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study	24
Prescription opioids and economic hardship in France	22
Setting incentives right with long-term risk adjustment	22
Production losses due to mortality associated with modifiable health risk factors in Poland	22
Workload and short sickness absences in a cohort of Finnish hospital employees	22